Blood Establishment Registration and Product Lising Form FDA 2830

ICR 200601-0910-004

OMB: 0910-0052

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
ICR Details
0910-0052 200601-0910-004
Historical Active 200212-0910-006
HHS/FDA
Blood Establishment Registration and Product Lising Form FDA 2830
Extension without change of a currently approved collection   No
Regular
Approved without change 03/10/2006
Retrieve Notice of Action (NOA) 01/26/2006
  Inventory as of this Action Requested Previously Approved
03/31/2009 03/31/2009 03/31/2006
2,875 0 3,167
1,533 0 1,753
0 0 0

All owners or operators of establishments that engage in the manufacturing of blood products are required to register pursuant to 21 CFR Part 607.

None
None


No

1
IC Title Form No. Form Name
Blood Establishment Registration and Product Lising Form FDA 2830 FDA-2830

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,875 3,167 0 0 -292 0
Annual Time Burden (Hours) 1,533 1,753 0 0 -220 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/26/2006


© 2024 OMB.report | Privacy Policy